ArticleOrphanet journal of rare diseases2019

Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group.

Eleonora Gaetani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.